Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,538
Total Claims
$894K
Drug Cost
795
Beneficiaries
$1,124
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,743 Pediatric Medicine providers
+129%
Opioid rate vs peers
3.6% vs 1.6% avg
-46%
Cost per patient vs peers
$1,124 vs $2,098 avg
-32%
Brand preference vs peers
10.2% vs 15.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.6%
Opioid Rate
384
Opioid Claims
$7,237
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,064 claims · $687K
Generic: 9,391 claims · $201K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 98 | $129K |
| Empagliflozin | 65 | $74K |
| Sitagliptin Phosphate | 45 | $63K |
| Semaglutide | 27 | $37K |
| Semaglutide | 14 | $30K |
| Rivaroxaban | 27 | $25K |
| Insulin Glargine,hum.Rec.Anlog | 32 | $23K |
| Fluticasone/Umeclidin/Vilanter | 12 | $16K |
| Dapagliflozin Propanediol | 11 | $16K |
| Budesonide/Formoterol Fumarate | 23 | $16K |
| Tirzepatide | 14 | $15K |
| Fluticasone/Vilanterol | 20 | $10K |
| Mirabegron | 19 | $10K |
| Insulin Degludec | 12 | $9,945 |
| Rosuvastatin Calcium | 520 | $8,912 |
Prescribing Profile
Patient Profile
74
Avg Age
66%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About